Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1821 (LINC01821)

Target
LINC01821
Molecular classification
Long non-coding RNA, Long intergenic non-coding RNA (lincRNA), Non-protein coding RNA
01

Overview

Long intergenic non-protein coding RNA 1821 (LINC01821) is a member of the long intergenic non-coding RNA (lincRNA) family, defined as autonomously transcribed RNAs longer than 200 nucleotides that do not encode proteins or overlap coding genes. LINC01821, like other lincRNAs, is believed to be involved in epigenetic and transcriptional regulation, including remodeling of chromatin structure, modulating the expression of neighboring or distal genes, and serving as a molecular scaffold for regulatory proteins or complexes. LincRNAs such as LINC01821 can exert their functions through sequence-dependent or sequence-independent mechanisms and are noted for their tissue specificity and regulatory versatility. Genetic and expression profiling studies have implicated LINC01821 as a potential diagnostic biomarker in gastric cancer, but no currently approved drugs are known to interact with this RNA molecule, and its use as a therapeutic target is not established[1][4][7].

Other names
LINC01821
02

Biological functions

Regulation of gene expressionChromatin remodeling and architectureTranscriptional regulation (including enhancer-associated activity)Fine-tuning of neighboring gene expression, often with tissue specificity
03

Disease associations

Cancer (notably involved in gastric cancer through diagnostic models)Possibly plays a role in other disease contexts influenced by lincRNAs, though specific evidence for LINC01821 is limited in the search results
04

Biomarkers

Potential diagnostic biomarker for gastric cancer (identified as a core gene in a diagnostic model with high accuracy and AUC score)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1821 (LINC01821).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1821 (LINC01821).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call